A review of HPLC methods used for determining the presence of meloxicam

Current Pharmaceutical Analysis

Volumn 9, Issue 1, 2013, Pages 69-76

  Brezovska, Monika ^a   Jampilek, Josef ^a   Opatrilova, Radka ^a  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Biological samples; HPLC; Meloxicam; Pharmaceutical preparations; Review

Indexed keywords

ALBUMIN; CYCLOOXYGENASE 2; DRUG METABOLITE; ETODOLAC; MELOXICAM; NIMESULIDE; PIROXICAM;

AMPEROMETRY; ARTHROPATHY; CAPILLARY ELECTROPHORESIS; CHEMOLUMINESCENCE; COMPARATIVE STUDY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; ELECTROCHEMISTRY; FLUORESCENCE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; ULTRAVIOLET RADIATION; VALIDATION PROCESS; VIDEODENSITOMETRY;

EID: 84873181966     PISSN: 15734129     EISSN: 1875676X     Source Type: Journal    
DOI: 10.2174/157341213804806179     Document Type: Review

References (44)

1. Starek, M.; Krzek, J. A review of analytical techniques for determination of oxicams, nimesulide and nabumetone. Talanta, 2009, 77(3), 925-942.
2. Zawilla, N.H.; Abdul-Azim Mohammad, M.; El kousy, N.M.; El-Moghazy A.S.M. Determination of meloxicam in bulk and pharmaceutical formulations. J. Pharm. Biomed. Anal., 2003, 32(6), 1135-1144.
3. Jantharaprapap, R.; Stagni, G. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int. J. Pharm., 2007, 343(1-2), 26-33.
4. Shukla, M.; Singh, G.; Sindhura, B.G.; Telang, A.G.; Rao, G.S.; Malik, J.K. Comparative plasma pharmacokinetics of meloxicam in sheep and goats following intravenous administration. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2007, 145(4), 528-532.
5. Dannhardt, G.; Kiefer, W.; Krämer, G.; Maehrlein, S.; Nowe, U.; Fiebich, B. The pyrrole moiety as a template for COX-1/COX-2 inhibitors. Eur. J. Med. Chem., 2000, 35(5), 499-510.
6. Hewett, S.J.; Bell, S.C.; Hewett, J.A. Contributions of cyclooxy-genase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol. Ther., 2006, 112(2), 335-357.
7. Grude, P.; Guittard, J.; Garcia, C.; Daoulas, I.; Thoulon, F.; Ebner, T. Excretion mass balance evaluation, metabolite profile analysis and metabolite identification in plasma and excreta after oral administration of [14C]-meloxicam to the male cat: preliminary study. J. Vet. Pharmacol. Ther., 2010, 33(4), 396-407.
8. Lehr, T.; Narbe, R.; Jöns, O.; Kloft, C.; Staab, A. Population pharmacokinetic modelling and simulation of single and multiple dose administration of meloxicam in cats. J. Vet. Pharmacol. Ther., 2010, 33(3), 277-286.
9. Demiralay, E.C.; Alsancak, G.; Ozkan, S.A. Determination of pKa values of nonsteroidal antiinflammatory drug-oxicams by RP-HPLC and their analysis in pharmaceutical dosage forms. J. Sep. Sci., 2009, 32(17), 2928-2936.
10. Ye, H.; Qiu, B.; Chen, J.; Lin, J.; Chen, G. Flow-injection analysis for meloxicam based on tris(2,2'-bipyridine) ruthenium(II)-Ce(IV) chemiluminescent system. Luminescence, 2009, 24(4), 260-265.
11. Han, H. Choi, H. Improved absorption of meloxicam via salt formation with ethanolamines. Eur. J. Pharm. Biopharm., 2007, 65(1), 99-103.
12. Bae, J.; Kim, M.; Jang, C.; Lee, S. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2007, 859(1), 69-73.
13. Salhab, A.S.; Gharaibeh, M.N.; Shomaf, M.S.; Amro, B.I. Meloxicam inhibits rabbit ovulation. Contraception, 2001, 63(6), 329-333.
14. Dasandi, B.; Shivaprakash G; Saroj, H.; Bhat, K.M. LC determination and pharmacokinetics of meloxicam. J. Pharm. Biomed. Anal., 2002, 28(5), 999-1004.
15. Yuan, Y.; Li, S.; Mo, F.; Zhong, D. Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm., 2006, 321(1-2), 117-123.
16. Yuan, Y.; Chen, X.; Zhong, D. Determination of meloxicam in human plasma by liquid chromatography-tandem mass spectrometry following transdermal administration. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2007, 852(1-2), 650-654.
17. Charkoftaki, G.; Kytariolos, J.; Macheras, P. Novel milk-based oral formulations: proof of concept. Int. J. Pharm., 2010, 390(2), 150-159.
18. Banerjee, R.; Chakraborty, H.; Sarkar, M. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2003, 59(6), 1213-1222.
19. van Antwerpen, P. Nève, J. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of nonsteroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Eur. J. Pharmacol., 2004, 496(1-3), 55-61.
20. Montejo, C.; Barcia, E.; Negro, S.; Fernández-Carballido, A. Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system. Int. J. Pharm., 2010, 387(1-2), 223-229.
21. Novakova, L.; Satinsky, D., Soloch, P. HPLC methods for the determination of simvastatin and atorvastatin, Trends Anal. Chem., 2008, 27, (4), 352-367.
22. Ji, H.Y.; Lee, H.W.; Kim, Y.H.; Jeong, D.W.; Lee, H.S. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005, 826(1-2), 214-219.
23. Wiesner, J.L.; de Jager, A.D.; Sutherland, F.C.; Hundt, H.K.; Swart, K.J.; Hundt, A.F.; Els, J. Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 785(1), 115-121.
24. Altinöz, S.; Nemutlu, E.; Kir, S. Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma. Farmaco, 2002, 57(6), 463-468.
25. Hassan, E.M. Spectrophotometric and fluorimetric methods for the determination of meloxicam in dosage forms. J. Pharm. Biomed. Anal., 2002, 27(5), 771-777.
26. Rao, N.R.; Meena, S.; Rao, R. A. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. J. Pharm. Biomed. Anal., 2005, 39(3-4), 349-363.
27. Rigato, H.M.; Mendes, G.D.; Borges, N.C.D.C.; Moreno, R.A. Meloxicam determination in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS) in Brazilian bioequivalence studies. Int. J. Clin. Pharmacol. Ther., 2006, 44(10), 489-498.
28. Baeyens, W.R.G.; Van der Weken, G.; Dhaeninck, E.; García-Campaña, A.M.; Vankeirsbilck, T.; Vercauteren, A.; Deprez, P. Application of an alkyl-diol silica precolumn in a column-switching system for the determination of meloxicam in plasma. J. Pharm. Biomed. Anal., 2003, 32(4-5), 839-846.
29. Velpandian, T.; Jaiswal, J.; Bhardwaj, R.K.; Gupta, S.K. Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. J. Chromatogr. B Biomed. Sci. Appl., 2000, 738(2), 431-436.
30. Gao, C.; Huang, J.; Jiao, Y.; Shan, L.; Liu, Y.; Li, Y.; Mei, X. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets. Int. J. Pharm., 2006, 322(1-2), 104-112.
31. Reyes, L.; Tinworth, K.D.; Li, K.M.; Yau, D.F.; Waters, K.A. Observer-blinded comparison of two nonopioid analgesics for postoperative pain in piglets. Pharmacol. Biochem. Behav., 2002, 73(3), 521-528.
32. Baert, K. De Backer, P. Comparative pharmacokinetics of three non-steroidal anti-inflammatory drugs in five bird species. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2003, 134(1), 25-33.
33. Igualada, C.; Moragues, F.; Pitarch, J. Rapid method for the determination of non-steroidal anti-inflammatory drugs in animal tissue by liquid chromatography-mass spectrometry with ion-trap detector. Anal. Chim. Acta, 2007, 586(1-2), 432-439.
34. Jedziniak, P.; Szprengier-Juszkiewicz, T.; Olejnik, M. In-house reference materials: 5-hydroxyflunixin and meloxicam in cow milk-preparation and evaluation. Anal. Chim. Acta, 2009, 637(1-2), 346-350.
35. Malone, E.M.; Dowling, G.; Elliott, C.T.; Kennedy, D.G.; Regan, L. Development of a rapid, multi-class method for the confirmatory analysis of anti-inflammatory drugs in bovine milk using liquid chromatography tandem mass spectrometry. J. Chromatogr. A, 2009, 1216(46), 8132-8140.
36. Gallo, P.; Fabbrocino, S.; Dowling, G.; Salini, M.; Fiori, M.; Perretta, G.; Serpe, L. Confirmatory analysis of non-steroidal antiinflammatory drugs in bovine milk by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. A, 2010, 1217(17), 2832-2839.
37. Elbary, A.A.; Foda, N.; Elkhateeb, M. Reversed phase liquid chromatographic determination of meloxicam in human plasma and its pharmacokinetic application. Anal. Lett., 2001, 34(7), 1175.
38. Chiou, A.H.; Yeh, M.; Chen, C.; Wang, D. Micronization of meloxicam using a supercritical fluids process. J. Supercrit. Fluids, 2007, 42(1), 120-128.
39. Vignaduzzo, S.E.; Castellano, P.M.; Kaufman, T.S. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations. J. Pharm. Biomed. Anal., 2008, 46(2), 219-225.
40. Arayne, M.S.; Sultana, N.; Siddiqui, F.A. A new RP-HPLC method for analysis of meloxicam in tablets. Pak. J. Pharm. Sci., 2005, 18(1), 58-62.
41. Joseph-Charles, J. Bertucat, M. Determination of meloxicam in tablet formulations by ultraviolet spectrophotometry and high-performance liquid chromatography. Anal. Lett., 1999, 32(10), 2051.
42. Taha, E.A.; Salama, N.N.; Abdel Fattah, L.E. Stability-indicating chromatographic methods for the determination of some oxicams. J. AOAC Int., 2004, 87(2), 366-373.
43. Luger, P.; Daneck, K.; Engel, W.; Trummlitz, G.; Wagner, K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur. J. Pharm. Sci., 1996, 4(3), 175-187.
44. Lu, Y.; Zhang, X.; Lai, J.; Yin, Z.; Wu, W. Physical characterization of meloxicam-β-cyclodextrin inclusion complex pellets prepared by a fluid-bed coating method. Particuology, 2009, 7(1), 1-8.